Nanoenergy in the pharmaceutical field represents a cutting-edge approach that harnesses the unique properties of nanomaterials to revolutionize drug delivery, diagnostics, and therapeutic interventions. The integration of nanotechnology into pharmaceutical research and development has paved the way for more efficient drug formulations and targeted delivery systems. Nano-sized drug carriers, such as liposomes and polymeric nanoparticles, enable precise control over drug release kinetics, enhancing therapeutic efficacy while minimizing side effects. Additionally, nanoscale materials play a crucial role in the development of advanced imaging techniques for early disease detection and monitoring. Nano energy in pharmaceuticals also extends to the design of smart materials that respond to specific physiological cues, further optimizing drug delivery.
This interdisciplinary synergy between nanotechnology and pharmaceuticals holds great promise in overcoming challenges associated with traditional drug delivery, opening new avenues for personalized medicine and improved patient outcomes. As research in this field continues to advance, the potential applications of nano energy in pharmaceuticals are poised to redefine the landscape of medical treatments.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India